Healthcare Trust Of America, Inc. HTA
Institutional shares held
310
0
calls
0
puts
Total value of holdings
$0
$0
calls
$0
puts
Market Cap
$6.69B
229,074,000
Shares Out.
Institutional ownership
0.0%
# of Institutions
2
We take great care to ensure that the data presented and summarized in this overview for HEALTHCARE TRUST OF AMERICA, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in HTA
Top Purchases
Top Sells
About HTA
Insider Transactions at HTA
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 05
2024
|
John Knox Singleton Director |
BUY
Open market or private purchase
|
Indirect |
6,500
+5.54%
|
$117,000
$18.24 P/Share
|
Sep 05
2024
|
James Joseph Iv Kilroy Director |
BUY
Open market or private purchase
|
Indirect |
12,900
+33.77%
|
$232,200
$18.26 P/Share
|
Sep 04
2024
|
Thomas N Bohjalian Director |
BUY
Open market or private purchase
|
Direct |
14,000
+24.89%
|
$238,000
$17.88 P/Share
|
Aug 30
2024
|
Peter F Sr Lyle Director |
BUY
Open market or private purchase
|
Indirect |
1,272
+13.5%
|
$21,624
$17.74 P/Share
|
Aug 29
2024
|
Peter F Sr Lyle Director |
BUY
Open market or private purchase
|
Indirect |
228
+3.21%
|
$3,876
$17.54 P/Share
|
Aug 20
2024
|
Thomas N Bohjalian Director |
BUY
Open market or private purchase
|
Direct |
6,000
+17.52%
|
$102,000
$17.45 P/Share
|
Aug 12
2024
|
Thomas N Bohjalian Director |
BUY
Open market or private purchase
|
Direct |
9,000
+28.8%
|
$153,000
$17.39 P/Share
|
Jun 25
2024
|
Thomas N Bohjalian Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,252
+38.37%
|
$132,032
$16.36 P/Share
|
May 21
2024
|
John Knox Singleton Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,443
+13.77%
|
$126,645
$15.99 P/Share
|
May 21
2024
|
Constance B Moore Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,443
+24.97%
|
$126,645
$15.99 P/Share
|
May 21
2024
|
Jay P Leupp Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,443
+20.46%
|
$126,645
$15.99 P/Share
|
May 21
2024
|
James Joseph Iv Kilroy Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,443
+22.09%
|
$126,645
$15.99 P/Share
|
May 21
2024
|
Ajay Gupta Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,443
+24.26%
|
$126,645
$15.99 P/Share
|
May 21
2024
|
Vicki U Booth Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,443
+16.28%
|
$126,645
$15.99 P/Share
|
May 21
2024
|
John V Abbott Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,443
+24.6%
|
$126,645
$15.99 P/Share
|
Feb 13
2024
|
Amanda L Callaway SVP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,677
+10.32%
|
$160,155
$15.22 P/Share
|
Feb 13
2024
|
Robert E Hull EVP - Investments |
BUY
Grant, award, or other acquisition
|
Direct |
24,639
+11.27%
|
$369,585
$15.22 P/Share
|
Feb 13
2024
|
John M Bryant Jr EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
22,175
+8.71%
|
$332,625
$15.22 P/Share
|
Feb 13
2024
|
Julie F. Wilson EVP - Operations |
BUY
Grant, award, or other acquisition
|
Direct |
22,175
+13.81%
|
$332,625
$15.22 P/Share
|
Feb 13
2024
|
J Christopher Douglas EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
24,639
+8.2%
|
$369,585
$15.22 P/Share
|
Last 12 Months Summary
Buy / Acquisition
322K
Shares
From
18
Insiders
Grant, award, or other acquisition | 272K shares |
---|---|
Open market or private purchase | 49.9K shares |
Sell / Disposition
105K
Shares
From
8
Insiders
Payment of exercise price or tax liability | 75.1K shares |
---|---|
Open market or private sale | 29.5K shares |